CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh (C2RS34) Stock Forecast & Price Target
C2RS34 Analyst Ratings
There are no analyst ratings in the last 3 months.
C2RS34 Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
No analyst ratings match these filters.
C2RS34 Financial Forecast
C2RS34 Earnings Forecast
Next quarter’s earnings estimate for C2RS34 is BRL 0.00 with a range of ― to ―. The previous quarter’s EPS was BRL 0.00. C2RS34 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year C2RS34 has Performed in-line its overall industry.
C2RS34 Sales Forecast
Next quarter’s sales forecast for C2RS34 is BRL 51.45M with a range of ― to ―. The previous quarter’s sales results were BRL 51.45M. C2RS34 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year C2RS34 has Performed in-line its overall industry.